Meningococcal Vaccines Market - Forecast (2022 - 2027) - PowerPoint PPT Presentation

About This Presentation
Title:

Meningococcal Vaccines Market - Forecast (2022 - 2027)

Description:

Meningococcal Vaccines Market size is expected to reach $4.2 billion by 2026, growing at a CAGR of 10.8% during the forecast period 2021-2026. Meningococcal vaccines are polysaccharide vaccines that are used to prevent diseases caused by meningococcus, which is a Gram-negative bacterium that can cause meningitis and other forms of meningococcal disease such as meningococcemia. – PowerPoint PPT presentation

Number of Views:0
Slides: 9
Provided by: Username withheld or not provided
Category: Other
Tags:

less

Transcript and Presenter's Notes

Title: Meningococcal Vaccines Market - Forecast (2022 - 2027)


1
Meningococcal Vaccines MarketMarket size,
Industry outlook, Market Forecast, Demand
Analysis, Market Share, Market Report 2022-2027
Contact Venkat Reddy sales_at_industryarc.com
(1) 970-236-3677
2
Download PDF Brochure
  • Meningococcal Vaccines Market size is expected to
    reach 4.2 billion by 2026, growing at a CAGR of
    10.8 during the forecast period 2021-2026.
  • Meningococcal vaccines are polysaccharide
    vaccines that are used to prevent diseases caused
    by meningococcus, which is a Gram-negative
    bacterium that can cause meningitis and other
    forms of meningococcal disease such as
    meningococcemia.

Inquiry Before Buying
Email sales_at_industryarc.com
3
Download PDF Brochure
  • Key Takeaways
  • North America Meningococcal Vaccines Market
    accounted for the highest revenue share in 2020
    and it is poised to dominate over the period
    2021-2026 owing to the growing approval of new
    vaccines to protect people against meningococcal
    meningitis.
  • The increasing demand for meningococcal conjugate
    vaccines for treating the infant population is
    driving the segment of Infants.

Inquiry Before Buying
Email sales_at_industryarc.com
4
Download PDF Brochure
Meningococcal Vaccines Market Segment
Analysis-By Type The Meningococcal Vaccines
Market based on the Type can be further segmented
into Bivalent, Quadrivalent, and Others. The
Quadrivalent segment held the largest share in
2020 and is also estimated to be the
fastest-growing segment with a CAGR of 11.6 over
the period 2021-2026. This growth is owing to the
growing usage from brands such as Menactra,
Menveo, and Nimenrix. The quadrivalent Conjugate
Vaccines are increasingly being used for the
active immunization of individuals.
Inquiry Before Buying
Email sales_at_industryarc.com
5
Download PDF Brochure
  • Meningococcal Vaccines Market Industry Outlook 
  • GlaxoSmithKline PLC,
  • Pfizer Inc,
  • Walvax Biotechnology Co Ltd,
  • Bio-Med Pvt Ltd,
  • Bio-Manguinhos,
  • Chongqing Zhifei Biological Products Co Ltd,
  • Incepta Pharmaceuticals Ltd,
  • Serum Institute of India Pvt. Ltd,
  • Sanofi S.A,

Inquiry Before Buying
Email sales_at_industryarc.com
6
Download PDF Brochure
Meningococcal Vaccines Market- Forecast(2022 -
2027) Learn More About the Report
_at_ https//bit.ly/3Yr07XM
Inquiry Before Buying
Email sales_at_industryarc.com
7
Download PDF Brochure
  • You Can Customize the Report as Per Your Need.
    We have included Some Customization Options
  • Company Profile
  • Analyst Briefing
  • Data Tables
  • Key Contacts
  • Free Customization
  • Purchase Full Report _at_https//www.industryarc.com/
    purchasereport.php?id19670

Inquiry Before Buying
Email sales_at_industryarc.com
8
Download PDF Brochure
For More Details Contact Venkat
Reddy Contact (1) 970-236-3677 Email
sales_at_industryarc.com Connect with us on LinkedIn
_at_ http//www.linkedin.com/company/industryarc
Contact (1) 970-236-3677
Inquiry Before Buying
Email sales_at_industryarc.com
Write a Comment
User Comments (0)
About PowerShow.com